EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+8.41%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.55B
AUM Growth
+$502M
(+9.9%)
Cap. Flow
+$203M
Cap. Flow
% of AUM
3.66%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
934
New
51
Increased
198
Reduced
144
Closed
33
Top Buys
| 1 |
Cintas
CTAS
|
$23.7M |
| 2 |
Sunrun
RUN
|
$18.3M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$14.6M |
| 4 |
NOVA
Sunnova Energy
NOVA
|
$14M |
| 5 |
Home Depot
HD
|
$13.5M |
Top Sells
| 1 |
Silicon Motion
SIMO
|
$25.9M |
| 2 |
NVIDIA
NVDA
|
$25.7M |
| 3 |
Visa
V
|
$16.9M |
| 4 |
Comcast
CMCSA
|
$16.5M |
| 5 |
TJX Companies
TJX
|
$14.5M |
Sector Composition
| 1 | Technology | 31.13% |
| 2 | Healthcare | 18.95% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Financials | 9.3% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Sun Life Financial
SLF
$32.4B
| $1.75M | 0.03% |
31,800
+23,300
| +274% | +$1.28M |
|
302
Apellis Pharmaceuticals
APLS
$3.55B
| $1.75M | 0.03% |
37,000
+20,000
| +118% | +$946K |
|
303
Kinross Gold
KGC
$26.9B
| $1.74M | 0.03% |
309,400
-210,300
| -40% | -$1.19M |
|
304
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $1.72M | 0.03% |
19,750
| – | – |
|
|
TWTR
305
DELISTED
Twitter, Inc.
TWTR
| $1.72M | 0.03% |
40,175
+40,000
| +22,857% | +$1.71M |
|
306
PTC Therapeutics
PTCT
$4.55B
| $1.7M | 0.03% |
41,800
| – | – |
|
307
Blackrock
BLK
$170B
| $1.69M | 0.03% |
1,851
-365
| -16% | -$333K |
|
308
Gartner
IT
$18.6B
| $1.68M | 0.03% |
+5,000
| New | +$1.68M |
|
309
Idexx Laboratories
IDXX
$51.4B
| $1.65M | 0.03% |
2,520
+825
| +49% | +$540K |
|
310
Royal Gold
RGLD
$12.2B
| $1.62M | 0.03% |
15,560
-11,060
| -42% | -$1.15M |
|
311
Nutanix
NTNX
$18.7B
| $1.62M | 0.03% |
50,000
-150,000
| -75% | -$4.86M |
|
|
GBT
312
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.62M | 0.03% |
53,500
| – | – |
|
313
Global Payments
GPN
$21.3B
| $1.62M | 0.03% |
12,054
+2,624
| +28% | +$352K |
|
314
Deere & Co
DE
$128B
| $1.6M | 0.03% |
4,619
+248
| +6% | +$85.7K |
|
315
Philip Morris
PM
$251B
| $1.59M | 0.03% |
16,861
+4,777
| +40% | +$450K |
|
316
Amicus Therapeutics
FOLD
$2.46B
| $1.58M | 0.03% |
132,000
| – | – |
|
317
Ionis Pharmaceuticals
IONS
$9.76B
| $1.57M | 0.03% |
51,300
| – | – |
|
318
Cadence Design Systems
CDNS
$95.6B
| $1.52M | 0.03% |
8,000
| – | – |
|
319
Canadian Natural Resources
CNQ
$63.2B
| $1.48M | 0.03% |
72,083
+23,075
| +47% | +$474K |
|
320
Q32 Bio
QTTB
$20.4M
| $1.47M | 0.03% |
22,083
+7,777
| +54% | +$516K |
|
321
American Express
AXP
$227B
| $1.46M | 0.03% |
8,934
+1,090
| +14% | +$179K |
|
322
Ultragenyx Pharmaceutical
RARE
$3.07B
| $1.42M | 0.03% |
17,210
| – | – |
|
323
Exelixis
EXEL
$10.2B
| $1.41M | 0.03% |
74,500
| – | – |
|
324
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.36M | 0.02% |
3
| – | – |
|
325
Denali Therapeutics
DNLI
$2.26B
| $1.35M | 0.02% |
30,600
| – | – |
|